1. Tun K, Shurko JF, Ryan L, Lee GC. Age-based health and economic burden of skin and soft tissue infections in the United States, 2000 and 2012. PLoS One. 2018;13(11):e0206893–3.
2. Kaye KS, Petty LA, Shorr AF, Zilberberg MD. Current epidemiology, etiology, and burden of acute skin infections in the United States. Clin Infect Dis. 2019;68(Suppl 3):S193–9.
3. Ioannou P, Tsagkaraki E, Athanasaki A, Tsioutis C, Gikas A. Gram-negative Bacteria as emerging pathogens affecting mortality in skin and soft tissue infections. Hippokratia. 2018;22(1):23–8.
4. Bassetti M, Vena A, Croxatto A, Righi E, Guery B. How to manage pseudomonas aeruginosa infections. Drugs Context. 2018;7:212527–7.
5. Leong HN, Kurup A, Tan MY, Kwa ALH, Liau KH, Wilcox MH. Management of Complicated Skin and Soft Tissue Infections with a special focus on the role of newer antibiotics. Infect Drug Resist. 2018;11:1959–74.